Skip to main content
Heidi Klepin, MD, Oncology, Winston-Salem, NC, Atrium Wake Forest Baptist

HeidiDKlepinMD, MS, FASCO

Oncology Winston-Salem, NC

Professor, Internal Medicine, Wake Forest University School of Medicine

Dr. Klepin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Klepin's full profile

Already have an account?

Education & Training

  • Wake Forest University Baptist Medical Center
    Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Wake Forest University School of Medicine
    Wake Forest University School of MedicineFellowship, Geriatric Medicine (Internal Medicine), 2001 - 2002
  • Wake Forest University School of Medicine
    Wake Forest University School of MedicineResidency, Internal Medicine, 1998 - 2001
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 1998

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1998 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Geriatric Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer  
    Aminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society

Abstracts/Posters

  • Alliance A041701 - a Randomized Phase 2/3 Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia (AML) Receiving Int...
    Heidi D. Klepin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Aging and Hematologic Disorders: Exploring the Evidence 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Friday Scientific Workshop on Hematology and Aging: From Bleeding Disorders to Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Hypertension and use of bevacizumab among patients treated in community settings. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Join now to see all

Other

Press Mentions

  • First-Line Cyramza in NSCLC Gets Split Decision from FDA Panel
    First-Line Cyramza in NSCLC Gets Split Decision from FDA PanelFebruary 27th, 2020
  • ODAC Cautiously Backs Keytruda in Early Bladder Cancer
    ODAC Cautiously Backs Keytruda in Early Bladder CancerDecember 17th, 2019
  • FDA Panel Split on PARP Inhibitor for Pancreatic Cancer
    FDA Panel Split on PARP Inhibitor for Pancreatic CancerDecember 17th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations